Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4.4M | 149 | 77.9% |
| Consulting Fee | $629,601 | 119 | 11.1% |
| Grant | $379,008 | 4 | 6.7% |
| Travel and Lodging | $131,674 | 238 | 2.3% |
| Honoraria | $93,647 | 24 | 1.7% |
| Food and Beverage | $13,991 | 164 | 0.2% |
| Education | $2,423 | 8 | 0.0% |
| Gift | $295.00 | 6 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $4.1M | 77 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $669,950 | 56 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $147,056 | 105 | $0 (2021) |
| Alkermes, Inc. | $108,666 | 80 | $0 (2024) |
| H. Lundbeck A S | $96,847 | 32 | $0 (2023) |
| Teva Pharmaceuticals USA, Inc. | $80,874 | 44 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $66,515 | 41 | $0 (2023) |
| Allergan, Inc. | $62,979 | 49 | $0 (2020) |
| PFIZER INC. | $48,481 | 7 | $0 (2019) |
| AbbVie Inc. | $46,866 | 39 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $47,980 | 39 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) ($28,436) |
| 2023 | $106,776 | 84 | AbbVie Inc. ($45,494) |
| 2022 | $46,858 | 24 | ITI, Inc. ($17,186) |
| 2021 | $91,330 | 35 | CIPLA USA INC. ($20,000) |
| 2020 | $543,332 | 65 | Sunovion Pharmaceuticals Inc. ($381,468) |
| 2019 | $544,141 | 133 | Takeda Pharmaceuticals U.S.A., Inc. ($382,230) |
| 2018 | $1.8M | 121 | Takeda Pharmaceuticals U.S.A., Inc. ($1.6M) |
| 2017 | $2.5M | 211 | Takeda Pharmaceuticals U.S.A., Inc. ($2.1M) |
All Payment Transactions
712 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $2,020.00 | General |
| 12/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,530.00 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/27/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $125.00 | General |
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $1,383.00 | General |
| 11/14/2024 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $4,977.00 | General |
| 10/21/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $707.63 | General |
| 10/07/2024 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $505.00 | General |
| 09/25/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Honoraria | Cash or cash equivalent | $1,140.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/22/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Honoraria | Cash or cash equivalent | $1,140.00 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $1,049.55 | General |
| 08/12/2024 | E.R. Squibb & Sons, L.L.C. | — | Travel and Lodging | Cash or cash equivalent | $264.00 | General |
| 07/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $4,200.00 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Education | In-kind items and services | $24.59 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | REXULTI (Drug) | Education | In-kind items and services | $24.59 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $148.53 | General |
| 06/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $4,800.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $338.11 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $338.11 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $145.83 | General |
| Category: PSYCHIATRY | ||||||
| 06/24/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Consulting Fee | Cash or cash equivalent | $505.00 | General |
| Category: CNS | ||||||
| 06/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Consulting Fee | Cash or cash equivalent | $5,400.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $262.38 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $200.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
| 06/05/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Travel and Lodging | In-kind items and services | $125.00 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Stephen Stahl, MD
Dr. Stephen Stahl, MD is a Specialist healthcare provider based in Carlsbad, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1710144167.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Stephen Stahl, MD has received a total of $5.7M in payments from pharmaceutical and medical device companies, with $47,980 received in 2024. These payments were reported across 712 transactions from 32 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($4.4M).
Practice Information
- Specialty Specialist
- Location Carlsbad, CA
- Active Since 05/21/2008
- Last Updated 05/21/2008
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1710144167
Products in Payments
- Trintellix (Drug) $2.4M
- Latuda (Drug) $233,464
- LATUDA (Drug) $208,810
- SEP-225289 (Drug) $200,000
- NUPLAZID (Drug) $131,114
- VRAYLAR (Drug) $104,507
- REXULTI (Drug) $85,804
- AUSTEDO (Drug) $72,340
- CAPLYTA (Drug) $66,316
- BRINTELLIX (Drug) $36,939
- CELEBREX (Drug) $32,573
- ARISTADA (Drug) $24,708
- ABILIFY MAINTENA (Drug) $19,915
- LIPITOR (Drug) $15,908
- CYMBALTA (Drug) $11,200
- Vivitrol 380 mg (Drug) $10,350
- SD809-TD (Drug) $7,443
- Nuplazid (Drug) $6,892
- LYBALVI (Drug) $6,633
- DISEASE EDUCATION (Drug) $6,250
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Carlsbad
Dr. Brian Reagan, M.d, M.D
Specialist — Payments: $2,837
Dr. Roberto Labayen, M.d, M.D
Specialist — Payments: $2,684
Gary Willard, M.d, M.D
Specialist — Payments: $377.13
Dr. Kim Janatpour, M.d, M.D
Specialist
Dr. Paul Gaspar, Dpt, DPT
Specialist
Dr. Ejub Hadzic, M.d, M.D
Specialist